InMed Pharmaceuticals Stock Forecast - Accumulation Distribution
| INM Stock | USD 1.07 0.04 3.60% |
InMed Stock outlook is based on your current time horizon. Although InMed Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of InMed Pharmaceuticals' systematic risk associated with finding meaningful patterns of InMed Pharmaceuticals fundamentals over time.
As of now, the RSI of InMed Pharmaceuticals' share price is approaching 40. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling InMed Pharmaceuticals, making its price go up or down. Momentum 40
Sell Extended
Oversold | Overbought |
Wall Street Target Price 20 | Quarterly Revenue Growth (0.11) |
Using InMed Pharmaceuticals hype-based prediction, you can estimate the value of InMed Pharmaceuticals from the perspective of InMed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
InMed Pharmaceuticals after-hype prediction price | USD 1.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of InMed Pharmaceuticals to cross-verify your projections. InMed Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine InMed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for InMed using various technical indicators. When you analyze InMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3105.36 | 3105.36 |
| Check InMed Pharmaceuticals Volatility | Backtest InMed Pharmaceuticals | Information Ratio |
InMed Pharmaceuticals Trading Date Momentum
| On January 26 2026 InMed Pharmaceuticals was traded for 1.07 at the closing time. Highest InMed Pharmaceuticals's price during the trading hours was 1.14 and the lowest price during the day was 1.07 . The net volume was 50.6 K. The overall trading history on the 26th of January did not cause price change. The trading delta at closing time to current price is 1.87% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare InMed Pharmaceuticals to competition |
Other Forecasting Options for InMed Pharmaceuticals
For every potential investor in InMed, whether a beginner or expert, InMed Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. InMed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in InMed. Basic forecasting techniques help filter out the noise by identifying InMed Pharmaceuticals' price trends.InMed Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InMed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of InMed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing InMed Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
InMed Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how InMed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InMed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying InMed Pharmaceuticals stock market strength indicators, traders can identify InMed Pharmaceuticals entry and exit signals to maximize returns.
InMed Pharmaceuticals Risk Indicators
The analysis of InMed Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in InMed Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inmed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.35 | |||
| Standard Deviation | 5.7 | |||
| Variance | 32.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for InMed Pharmaceuticals
The number of cover stories for InMed Pharmaceuticals depends on current market conditions and InMed Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that InMed Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about InMed Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
InMed Pharmaceuticals Short Properties
InMed Pharmaceuticals' future price predictability will typically decrease when InMed Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of InMed Pharmaceuticals often depends not only on the future outlook of the potential InMed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InMed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 976 K | |
| Cash And Short Term Investments | 11.1 M |
Check out Historical Fundamental Analysis of InMed Pharmaceuticals to cross-verify your projections. To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.09) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.